# Plerixafor in Diabetic Wound Healing

> **NCT02790957** · PHASE2 · TERMINATED · sponsor: **Gian Paolo Fadini** · enrollment: 25 (actual)

## Conditions studied

- Diabetes
- Wounds
- Critical Limb Ischemia

## Interventions

- **DRUG:** Plerixafor
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02790957
- **Lead sponsor:** Gian Paolo Fadini
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06
- **Primary completion:** 2019-08
- **Final completion:** 2019-11
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Safety reasons
- **Last updated:** 2019-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02790957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02790957, "Plerixafor in Diabetic Wound Healing". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02790957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*